Porton Pharma Solutions Ltd
SZSE:300363
Porton Pharma Solutions Ltd
Revenue
Porton Pharma Solutions Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Porton Pharma Solutions Ltd
SZSE:300363
|
Revenue
¥4.9B
|
CAGR 3-Years
35%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Porton Pharma Solutions Ltd's Revenue?
Revenue
4.9B
CNY
Based on the financial report for Sep 30, 2023, Porton Pharma Solutions Ltd's Revenue amounts to 4.9B CNY.
What is Porton Pharma Solutions Ltd's Revenue growth rate?
Revenue CAGR 5Y
32%
Over the last year, the Revenue growth was -23%. The average annual Revenue growth rates for Porton Pharma Solutions Ltd have been 35% over the past three years , 32% over the past five years .